Categories: New Launches

Atrimed Pharmaceuticals Introduce – Vyvuz: A Capsule that can Inhibit Viral Replication

Bangalore, January 15, 2022: Bangalore based Atrimed Pharmaceuticals recently launched their new find ‘Vyvuz Capsules’, a highly researched product licensed by the “Drug Authority of Kerala” that has been shown to inhibit the virus by up to 99.9%.

In the wake of the Omicron threat, it has become imperative to have a multi-pronged strategy to combat SARS CoV2. Dr. Hrishikesh Damle, M D & CEO – Atrimed Pharma stated that “As we know, vaccines are a good way to prevent the severity of the disease.” He continued, “Other measures like medicines that can prevent the replication of the virus also have a major role. With the ease of use and affordable price, all primary contacts, those who are travelling, attending gatherings or school-going children, can be protected against the virus with the addition of Vyvuz to existing measures.” Since it is known to be safe, Vyvuz has ingredients that have been tested in the Government of India Biotechnology labs and have been shown to inhibit the virus by up to 99.9%.

It is going to take longer to achieve 100% vaccination with two doses among the eligible population. Children aged 15 to 18 are recently approved to be vaccinated. A booster for all is a distant dream currently. At this juncture, Vyvuz comes as a welcome alternative that can be added to the current effort. This formulation has been tested against the ‘Delta’ variant and was found to be effective. AI based studies prove that it is also effective against the ‘Omicron’ variant.

The formulation contains Centella Asiatica, Withania Somnifera, and Andrographis Paniculata. Atrimed has conducted In-Silico, In-Vitro, In-Vivo, Phase 1 and Phase 2 clinical trials. The formulation was proven to be effective in reducing inflammatory markers and hence early symptomatic relief in COVID patients. The present formulation has been developed through the meticulous research carried out by Atrimed, and we request all Ayurvedic Doctors to judicially prescribe the product.

Newsvoir

The Pharma Times News Bureau

Recent Posts

SpOvum® Launches ARTGPT Redefining Patient Support in Assisted Reproductive Technology (ART)

Launched for 1st time in India, ARTGPT is designed to address queries regarding A.R.T treatments Product created…

3 days ago

Empowering Women in Uniform: P. D. Hinduja Hospital and Medical Research Centre organizes a special Breast Cancer Examination camp for Mumbai Police

Mumbai, October 29, 2024: P. D. Hinduja Hospital & Medical Research Centre today started a…

3 days ago

MoEFCC accused of National Medical Devices Policy violations by Industry Associations

 Industry leaders call for the Prime Minister’s intervention in the long-lasting issue of allowing imports…

3 days ago

Beyond the Scale: The Psychological Impact of Obesity

By Dr. Smrithi D Nayak, Consultant - Obstetrics & Gynaecology, Aster RV Hospital, Bengaluru Obesity,…

3 days ago

From Dreams to Reality: The Remarkable Entrepreneurial Journey of Dr. Satish Wagh in the Pharmaceutical Industry

New Delhi, October 26, 2024: Dr. Satish Wagh's journey is a remarkable testament to ambition and…

5 days ago

Polio-Free Bharat Takes Center Stage as Rotary Hosts World Polio Day Celebration

New Delhi, October 25, 2024: On the occasion of World Polio Day, a grand celebration…

6 days ago